BPTH Bio-Path Holdings to $19.6??

NASDAQ:BPTH   Bio-Path Holdings, Inc
Bio-Path Holdings Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia. (

The Market Cap is only 49.678M

I`ve extended the Fibonacci tool to measure the next price target and it`s 19.62usd.

If you are interested to test some amazing BUY and SELL INDICATORS that i use, which give the signal at the beginning of the candle, not at the end of it, just leave me a message!


Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter